+ Watch IBB
on My Watchlist
Exchange Traded Funds
If the previous 30 years were dominated by a semiconductor / IT revolution, the next 30 will be dominated by biotech. I'm a scientist working now at a large biotech, but I'm not a biologist by training (I'm a physicist - used to work in semiconductors). I can tell you that the pace of technology innovation in biotech right now is nothing short of breathtaking. Medicine will be completely transformed 20-30 years from now. While I'm not smart enough to know which micro or small cap biotech will or won't make it, biotech ETF's like IBB, FBT, etc are a great way to ride this wave, and will continue to destroy the broader market for the next decades. I cannot emphasize this enough - the scientific tools are now in place to understand and manipulate biology in ways that will completely transform medicine as we know it.
The biotech sector has been taking names and kicking butts for more than 10 years, and I think it still has a lot of life left in it, in spite of claims of "frothiness" and "bubbles." In fact, this ETF has done better than mid-, small-, or large-cap stock ETFs in both bear and bull markets in recent years. IBB also has the broadest number of holdings (150) of any biotech ETF, lessening the impact of any one company's uncertain fortunes.
Almost every day you read about some breakthrough results from a biotech company you've never heard of. What better way to make sure you get a piece of all that than to buy the biggest biotech ETF?
Wow, what a bubble.
Biotech is poised to better the market over the next 5 years. IBB should do a bit better than the general biotech industry because of its focus on larger equities.
Science and drug development are not doing well, but biotech and life sciences companies are on a tear!
This is my first CAP and IBB did well yday
Biotech is a safety net for now until energy cost catches up to demand,
Bio tech will continue to lead the market
Biotechs are strong this year.
Playing individual biotech stocks is risky business. This is probably the least risky way to play the sector without taking a chance of waking up one morning to see the company's drug was rejected and opens down 50%+ on an FDA rejection.
Price action here just looks off.
My choices in Biotech are an absolute disaster. Nonetheless, I realize that the sector has some wonderful successes and the needs of the boomer generation plus some "newly discovered" illnesses require new medicines. That makes Biotech a sector to have a presence in.Porte is our resident expert in this area and I am choosing this at his suggestion. It is worth noting that the only Biotech firms that have ever rewarded me - on CAPS or RL - are the ones that Porte has suggested to me. His suggestions are enough for me to add this to CAPS if not to add RL funds to.
The age is finally right
Betting to outperform the 500 this leg down.
loading up on biotech
I don't dislike biotech (alliterative double negative for you). However, I am willing to say that there are more bad biotech companies than good. Unfortunately, an ETF is going to have both the good and the bad so I'm going to say that a better way to play the industry is to do some extra research and find out what's actually going to work (though I may have an advantage here cuz I'm living on a campus where some of the best biotech research is being conducted)
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions